Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
496.4 INR | +0.32% | -4.77% | +13.51% |
May. 06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
Mar. 13 | Ingerø Reiten Investment Divests Navamedic Stake in NOK95 Million Deal | MT |
Sales 2022 | 33.48B 401M | Sales 2023 | 35.28B 423M | Capitalization | 31.66B 379M |
---|---|---|---|---|---|
Net income 2022 | 5.18B 62M | Net income 2023 | 9.28B 111M | EV / Sales 2022 | 1.44 x |
Net Debt 2022 | 27.61B 331M | Net Debt 2023 | 22.41B 268M | EV / Sales 2023 | 1.53 x |
P/E ratio 2022 |
3.95
x | P/E ratio 2023 |
3.41
x | Employees | 606 |
Yield 2022 |
4.26% | Yield 2023 |
2.75% | Free-Float | 48.2% |
Latest transcript on Nava Limited
1 day | +0.32% | ||
1 week | -4.77% | ||
Current month | -1.15% | ||
1 month | -2.30% | ||
3 months | +0.48% | ||
6 months | +23.59% | ||
Current year | +13.51% |
Managers | Title | Age | Since |
---|---|---|---|
Ashwin Devineni
CEO | Chief Executive Officer | 41 | 17-08-17 |
Sultan A. Baig
DFI | Director of Finance/CFO | 46 | 20-01-29 |
V. S. N. Raju
CMP | Compliance Officer | 54 | 16-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 81-07-31 | |
Ashwin Devineni
CEO | Chief Executive Officer | 41 | 17-08-17 |
Devineni Ashok
CHM | Chairman | 67 | 81-08-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 496.4 | +0.32% | 9,550 |
24-05-09 | 494.8 | -3.52% | 21,645 |
24-05-08 | 512.8 | +3.10% | 13,385 |
24-05-07 | 497.4 | -3.05% | 11,670 |
24-05-06 | 513.1 | -1.56% | 69,382 |
Delayed Quote Bombay S.E., May 10, 2024 at 06:00 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.51% | 862M | |
+14.63% | 890B | |
0.00% | 239B | |
+28.01% | 179B | |
-3.24% | 132B | |
+42.08% | 85.9B | |
-4.43% | 74.7B | |
-9.50% | 54.74B | |
-25.00% | 38.39B | |
+39.22% | 37.28B |
- Stock Market
- Equities
- NAVA Stock